Iron Triangle Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-281,992
Closed -$37.7M 33
2024
Q2
$37.7M Buy
+281,992
New +$53.4M 3.84% 15
2024
Q1
Sell
-150,000
Closed -$30.5M 33
2023
Q4
$30.5M Buy
+150,000
New +$24.3M 3.95% 13
2023
Q3
Sell
-70,000
Closed -$22.7M 26
2023
Q2
$22.7M Hold
70,000
3.04% 14
2023
Q1
$16.4M Sell
70,000
-10,000
-13% -$2.53M 2.36% 19
2022
Q4
$20.2M Sell
80,000
-20,000
-20% -$4.26M 3.61% 11
2022
Q3
$17.7M Sell
100,000
-13,938
-12% -$2.8M 3.1% 15
2022
Q2
$20.8M Buy
+113,938
New +$22.7M 2.7% 17
2020
Q4
Sell
-70,000
Closed -$9.03M 32
2020
Q3
$9.03M Sell
70,000
-46,054
-40% -$5.07M 2.02% 20
2020
Q2
$10.1M Buy
+116,054
New +$8.92M 2.54% 20

Other funds holding INSP

Iron Triangle Partners's INSP Position: Q3 2024 in Review

Iron Triangle Partners sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 281,992 shares — an estimated $37.7M sold.

Iron Triangle Partners first reported a position in INSP in Q2 2020 and held it in 9 quarters. The position peaked at $37.7M in Q2 2024. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

  • Iron Triangle Partners reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
  • Iron Triangle Partners sold 281,992 Inspire Medical Systems shares in Q3 2024, an estimated $37.7M.
  • Iron Triangle Partners first reported a position in Inspire Medical Systems in Q2 2020 and held it in 9 quarters.
  • Iron Triangle Partners's Inspire Medical Systems position peaked at $37.7M in Q2 2024.
  • 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Iron Triangle Partners's 13F filing for Q3 2024, filed 14 Nov 2024.